Stay up to date with the most recent announcements from the media

Lifesciences

Economic Times

Apr 27, 2023

Nkure raises pre-Series A round

The company is pioneering affordable NK cell therapy for the treatment of Cancer. Nkure is scaling rapidly from its first year of inception having successfully developed an NK cell platform at laboratory scale coupled with agreements with CDMOs in India and the US. It has also secured exclusive licenses to a specialized CAR and related technologies to enable allogenic cell therapy, the first of its kind in India.

Join our press mailing list

Stay updated with the latest news and press releases from Endiya Partners.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Covering us in your story?

Use our media kit

All Sectors

Sort By

BluJ Aero secures $2.25 million in funding led by Endiya Partners

Myelin Foundry's Edge AI is transforming user experiences

Eyestem files for IND approval for its product to treat geographic atrophy

Nkure raises pre-Series A round

Join our press mailing list

Covering us in your story?

News Articles

Filter News

All Sectors

Sort By

Join our press mailing list

Covering us in your story?